Retour
Fourchette du Jour
39,09 €
40,78 €
Fourchette 52 Semaines
5,49 €
42,88 €
Volume
457 549
Moyenne 50J / 200J
34,01 €
/
23,79 €
Clôture Précédente
41,56 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -14,2 | 0,3 |
| P/B | 3,2 | 2,9 |
| ROE % | -24,7 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
55,86 €
+40.0%
Low: 40,00 €
High: 75,00 €
BPA Prévisionnel
-2,36 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-4,44 €
-4,44 € – -4,44 €
|
40 M | 5 |
| FY2029 |
-3,99 €
-3,99 € – -3,99 €
|
0 | 2 |
| FY2028 |
-3,24 €
-4,50 € – -1,74 €
|
0 | 7 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -88,42M
PEG of 0,24 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-24,69%
ROIC-19,32%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio22,37
Interest Coverage0,00
Valorisation
P/E Ratio
-14,17
P/B Ratio3,17
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -105,43M |
| ROE | -24,69% | ROA | -21,58% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -88,42M |
| ROIC | -19,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 22,37 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,17 | P/B Ratio | 3,17 |
| P/S Ratio | N/A | PEG Ratio | 0,24 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,49B | Enterprise Value | 1,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -105,43M | -83,72M | -5,34M | -9,93M | -19,32M |
| EPS (Diluted) | -2,31 | -4,99 | -4,44 | -8,27 | -16,68 |
| Gross Profit | -83 000,0 | -27 000,0 | -111 000,0 | -114 000,0 | -91 000,0 |
| Operating Income | -122,05M | -88,12M | -7,30M | -9,84M | -19,34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 488,62M | 396,02M | 37,86M | 43,09M | 54,92M |
| Total Liabilities | 16,69M | 13,80M | 841 000,0 | 1,41M | 3,88M |
| Shareholders' Equity | 471,93M | 382,22M | 37,02M | 41,67M | 51,04M |
| Total Debt | 1,93M | 968 000,0 | 280 000,0 | 383 000,0 | 483 000,0 |
| Cash & Equivalents | 46,94M | 61,58M | 37,43M | 42,45M | 53,36M |
| Current Assets | 343,86M | 376,87M | 37,59M | 42,70M | 54,42M |
| Current Liabilities | 15,37M | 13,04M | 637 000,0 | 1,13M | 3,50M |